Skip to main content
. 2014 Apr 15;9(8):851–856. doi: 10.4103/1673-5374.131611

Figure 5.

Figure 5

Competitive inhibition of binding to acetylcholine receptor (AChR) in myasthenia gravis (MG) patient sera by single-chain single-chain variable domain fragment 637-human serum albumin (scFv637-HSA).

The capacity of ScFv637-HSA to protect human AChR from binding by MG patient sera was tested by competitive ELISA. The result is expressed as a percentage of inhibition of binding of MG patient sera (mean ± SEM).